Danaher Corp
NYSE:DHR

Watchlist Manager
Danaher Corp Logo
Danaher Corp
NYSE:DHR
Watchlist
Price: 240.75 USD 1.76%
Market Cap: 173.9B USD
Have any thoughts about
Danaher Corp?
Write Note

Danaher Corp
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Danaher Corp
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Danaher Corp
NYSE:DHR
Total Liabilities & Equity
$80.6B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
9%
Thermo Fisher Scientific Inc
NYSE:TMO
Total Liabilities & Equity
$100.4B
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
9%
West Pharmaceutical Services Inc
NYSE:WST
Total Liabilities & Equity
$3.7B
CAGR 3-Years
5%
CAGR 5-Years
11%
CAGR 10-Years
8%
Mettler-Toledo International Inc
NYSE:MTD
Total Liabilities & Equity
$3.3B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
5%
Agilent Technologies Inc
NYSE:A
Total Liabilities & Equity
$11B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
1%
IQVIA Holdings Inc
NYSE:IQV
Total Liabilities & Equity
$27.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
24%
No Stocks Found

Danaher Corp
Glance View

Market Cap
173.9B USD
Industry
Life Sciences Tools & Services
Economic Moat
Narrow

Danaher Corporation, a dynamic and innovative global science and technology company, has established itself as a leader in the life sciences, diagnostics, water quality, and applied solutions sectors. Founded in 1969, Danaher has consistently pursued a strategy of acquiring and nurturing businesses that align with its core focus on advancing health and enhancing the quality of life. By leveraging its strong operational framework known as the Danaher Business System (DBS), the company excels in driving efficiency and innovation across its diverse portfolio. With a commitment to R&D, Danaher continually develops cutting-edge technologies that address critical challenges faced by healthcare, environmental monitoring, and industrial applications. From its beginnings, Danaher has built a reputation for strong organic growth and robust financial performance. Investors are drawn to its disciplined approach to acquisitions, which not only enhances revenue streams but also integrates companies that provide synergistic benefits. With a solid financial foundation characterized by impressive margins and consistently high return on investment, Danaher appears well-positioned for long-term growth. As global demand for health and environmental solutions continues to rise, Danaher’s strategic investments and innovative capabilities make it a compelling choice for investors seeking exposure to the essential sectors of life sciences and diagnostics.

DHR Intrinsic Value
191.95 USD
Overvaluation 20%
Intrinsic Value
Price

See Also

What is Danaher Corp's Total Liabilities & Equity?
Total Liabilities & Equity
80.6B USD

Based on the financial report for Sep 27, 2024, Danaher Corp's Total Liabilities & Equity amounts to 80.6B USD.

What is Danaher Corp's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
9%

Over the last year, the Total Liabilities & Equity growth was -8%. The average annual Total Liabilities & Equity growth rates for Danaher Corp have been -1% over the past three years , 6% over the past five years , and 9% over the past ten years .

Back to Top